Trial intelligence / Profile preview

Dexmedetomidine for perioperative tachyarrhythmia prevention and management

ChiCTR2300077981Phase 4Recruiting

Sponsor
Leshan People's Hospital
Start
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in tachyarrhythmia and arrhythmia (2 arms), sponsored by Leshan People's Hospital. Primary endpoints: Heart rate, Mean arterial pressure and 2 more. Started Nov 2023; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

tachyarrhythmiaarrhythmia

Beyond the preview

Go deeper on ChiCTR2300077981.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300077981.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call